These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 11358814

  • 1. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.
    Yamamura H, Hashio M, Noguchi M, Sugenoya Y, Osakada M, Hirano N, Sasaki Y, Yoden T, Awata N, Araki N, Tatsuta M, Miyatake SI, Takahashi K.
    Cancer Res; 2001 May 15; 61(10):3969-77. PubMed ID: 11358814
    [Abstract] [Full Text] [Related]

  • 2. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 3. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T, Rabkin SD, Martuza RL.
    Cancer Res; 2006 Oct 15; 66(20):10127-35. PubMed ID: 17047077
    [Abstract] [Full Text] [Related]

  • 4. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 5. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant.
    Mineta T, Rabkin SD, Martuza RL.
    Cancer Res; 1994 Aug 01; 54(15):3963-6. PubMed ID: 8033122
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May 01; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

  • 7. Oncolytic recombinant herpes simplex virus for treatment of orthotopic liver tumors in nude mice.
    Chung YS, Miyatake S, Miyamoto A, Miyamoto Y, Dohi T, Tanigawa N.
    Int J Oncol; 2006 Apr 01; 28(4):793-8. PubMed ID: 16525626
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.
    J Gene Med; 2006 Jun 01; 8(6):679-89. PubMed ID: 16570242
    [Abstract] [Full Text] [Related]

  • 9. Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo.
    Miyatake SI, Tani S, Feigenbaum F, Sundaresan P, Toda H, Narumi O, Kikuchi H, Hashimoto N, Hangai M, Martuza RL, Rabkin SD.
    Gene Ther; 1999 Apr 01; 6(4):564-72. PubMed ID: 10476216
    [Abstract] [Full Text] [Related]

  • 10. Aberrant methylation and silencing of the calponin gene in human sarcoma cells.
    Yamamura H, Yoshikawa H, Takahashi K.
    Anticancer Res; 2003 Apr 01; 23(1A):107-14. PubMed ID: 12680201
    [Abstract] [Full Text] [Related]

  • 11. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.
    Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637
    [Abstract] [Full Text] [Related]

  • 12. A strict-late viral promoter is a strong tumor-specific promoter in the context of an oncolytic herpes simplex virus.
    Fu X, Meng F, Tao L, Jin A, Zhang X.
    Gene Ther; 2003 Aug 01; 10(17):1458-64. PubMed ID: 12900760
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):943-8. PubMed ID: 15329284
    [Abstract] [Full Text] [Related]

  • 14. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 02; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 15. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S.
    Cancer Res; 2001 Aug 01; 61(15):5796-802. PubMed ID: 11479218
    [Abstract] [Full Text] [Related]

  • 16. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
    Miettinen MM, Sarlomo-Rikala M, Kovatich AJ, Lasota J.
    Mod Pathol; 1999 Aug 01; 12(8):756-62. PubMed ID: 10463476
    [Abstract] [Full Text] [Related]

  • 17. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
    Huard J, Goins WF, Glorioso JC.
    Gene Ther; 1995 Aug 01; 2(6):385-92. PubMed ID: 7584113
    [Abstract] [Full Text] [Related]

  • 18. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW, Morris JC, Ehninger G, Ramsey WJ.
    J Gene Med; 2004 Jun 01; 6(6):652-62. PubMed ID: 15170736
    [Abstract] [Full Text] [Related]

  • 19. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y, Shen K, Yu JR.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307
    [Abstract] [Full Text] [Related]

  • 20. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 06; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.